Abstract:Metastasis causes greater than 90% of cancer-associated deaths, presenting huge challenges for detection and efficient treatment of cancer due to its high heterogeneity and widespread dissemination to various organs. Therefore, it is imperative to combat cancer metastasis, which is the key to achieving complete cancer eradication. Immunotherapy as a systemic approach has shown promising potential to combat metastasis. However, current clinical immunotherapies are not effective for all patients or all types of cancer metastases owing to insufficient immune responses. In recent years, immunological nanomaterials with intrinsic immunogenicity or immunomodulatory agents with efficient loading have been shown to enhance immune responses to eliminate metastasis. In this review, we would like to summarize various types of immunological nanomaterials against metastasis. Moreover, this review will summarize a series of immunological nanomaterial-mediated immunotherapy strategies to combat metastasis, including immunogenic cell death, regulation of chemokines and cytokines, improving the immunosuppressive tumour microenvironment, activation of the STING pathway, enhancing cytotoxic natural killer cell activity, enhancing antigen presentation of dendritic cells, and enhancing chimeric antigen receptor T cell therapy. Furthermore, the synergistic anti-metastasis strategies based on the combinational use of immunotherapy and other therapeutic modalities will also be introduced. In addition, the nanomaterial-mediated imaging techniques (e.g., optical imaging, magnetic resonance imaging, computed tomography, photoacoustic imaging, surface-enhanced Raman scattering, radionuclide imaging, etc.) for detecting metastasis and monitoring anti-metastasis efficacy are also summarized. Finally, the current challenges and future prospects of immunological nanomaterial-based anti-metastasis are also elucidated with the intention to accelerate its clinical translation.

Development of Individualized Anti-Metastasis Strategies by Engineering Nanomedicines.

Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages

Emerging Nanomedicine-Based Therapeutics for Hematogenous Metastatic Cascade Inhibition: Interfering with the Crosstalk Between “seed and Soil”

Bioengineering nanomaterials for tumor therapy and anti-metastasis

The progress and perspective of nanoparticle-enabled tumor metastasis treatment

Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.

Immunological nanomaterials to combat cancer metastasis

Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy

Nanotechnology-enhanced Immunotherapy for Metastatic Cancer

Cancer Bone Metastases and Nanotechnology-Based Treatment Strategies

Nanotechnology-based Intelligent Drug Design for Cancer Metastasis Treatment

Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis

MSN Anti‐Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis Inhibition

Emerging landscapes of nanosystems based on pre-metastatic microenvironment for cancer theranostics

Targeted nanostrategies eliminate pre-metastatic niche of cancer

Key processes in tumor metastasis and therapeutic strategies with nanocarriers: a review

Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery

Anti-metastatic drug development, overview and perspectives

Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation

Multi-stage mechanisms of tumor metastasis and therapeutic strategies

Emerging Nanomedicines Strategies Focused on Tumor Microenvironment Against Cancer Recurrence and Metastasis